These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 12714902)

  • 41. Long-term renoprotective effect of angiotensin-converting enzyme inhibition in non-insulin-dependent diabetes mellitus. A 7-year follow-up study.
    Ravid M; Lang R; Rachmani R; Lishner M
    Arch Intern Med; 1996 Feb; 156(3):286-9. PubMed ID: 8572838
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Telmisartan lowers albuminuria in type 2 diabetic patients treated with angiotensin enzyme inhibitors.
    Mazerska M; Myśliwiec M
    Adv Med Sci; 2009; 54(1):37-40. PubMed ID: 19505872
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Oxidative stress and nitric oxide synthase in rat diabetic nephropathy: effects of ACEI and ARB.
    Onozato ML; Tojo A; Goto A; Fujita T; Wilcox CS
    Kidney Int; 2002 Jan; 61(1):186-94. PubMed ID: 11786100
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Add-on angiotensin receptor blocker in patients who have proteinuric chronic kidney diseases and are treated with angiotensin-converting enzyme inhibitors.
    Kanno Y; Takenaka T; Nakamura T; Suzuki H
    Clin J Am Soc Nephrol; 2006 Jul; 1(4):730-7. PubMed ID: 17699280
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Use of losartan in reducing microalbuminuria in normotensive patients with type-2 diabetes mellitus.
    Agha A; Bashir K; Anwar E
    Nepal Med Coll J; 2007 Jun; 9(2):79-83. PubMed ID: 17899953
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Angiotensin inhibition or blockade for the treatment of patients with quiescent lupus nephritis and persistent proteinuria.
    Tse KC; Li FK; Tang S; Tang CS; Lai KN; Chan TM
    Lupus; 2005; 14(12):947-52. PubMed ID: 16425574
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Renal damage associated with proteinuria.
    Praga M; Morales E
    Kidney Int Suppl; 2002 Dec; (82):S42-6. PubMed ID: 12410854
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Diabetic nephropathy and pregnancy: the effect of ACE inhibitors prior to pregnancy on fetomaternal outcome.
    Hod M; van Dijk DJ; Karp M; Weintraub N; Rabinerson D; Bar J; Peled Y; Erman A; Boner G; Ovadia J
    Nephrol Dial Transplant; 1995 Dec; 10(12):2328-33. PubMed ID: 8808235
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Over 11 years of stable renal function after remission of nephrotic-range proteinuria in type I diabetics treated with an ACE inhibitor.
    McGregor D; Bailey RR
    Nephron; 1997; 76(3):270-5. PubMed ID: 9226226
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Type II Diabetes Patients with Proteinuria and the Recovery of Their Metabolic Parameters.
    Ya-Zhuo L; Keqi W; Xiang L; Bin C
    Cell Biochem Biophys; 2015 Dec; 73(3):593-5. PubMed ID: 27259298
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Comparative evaluation of fosinopril and herbal drug Dioscorea bulbifera in patients of diabetic nephropathy.
    Singh RG; Rajak M; Ghosh B; ; Agrawal A; Dubey GP
    Saudi J Kidney Dis Transpl; 2013 Jul; 24(4):737-42. PubMed ID: 23816723
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Relationship between autonomic function and progression of renal disease in diabetic proteinuria: clinical correlations and implications for blood pressure control.
    Weinrauch LA; Kennedy FP; Gleason RE; Keough J; D'Elia JA
    Am J Hypertens; 1998 Mar; 11(3 Pt 1):302-8. PubMed ID: 9544870
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Proteinuria in diabetic nephropathy: treatment and evolution.
    Campbell RC; Ruggenenti P; Remuzzi G
    Curr Diab Rep; 2003 Dec; 3(6):497-504. PubMed ID: 14611747
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Integrated Treatment of Prostaglandin E1 and Angiotensin-Converting Enzyme Inhibitor in Diabetic Kidney Disease Rats: Possible Role of Antiapoptosis in Renal Tubular Epithelial Cells.
    Mou Y; Zhang Y; Guo C; Zhao J; Zhang Z; Zhou X; Dong J; Liao L
    DNA Cell Biol; 2018 Feb; 37(2):133-141. PubMed ID: 29185789
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Diabetic nephropathy in children and adolescents: a critical review with particular reference to angiotensin-converting enzyme inhibitors.
    Chiarelli F; Casani A; Verrotti A; Morgese G; Pinelli L
    Acta Paediatr Suppl; 1998 Oct; 425():42-5. PubMed ID: 9822193
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Remission and regression of diabetic nephropathy.
    Makino H; Nakamura Y; Wada J
    Hypertens Res; 2003 Jul; 26(7):515-9. PubMed ID: 12924617
    [TBL] [Abstract][Full Text] [Related]  

  • 57. [Changes in renal protein excretion and kidney function in type I diabetic patients during and following pregnancy in relation to the stage of preexistent diabetic nephropathy].
    Biesenbach G; Stöger W; Zazgornik J
    Klin Wochenschr; 1987 Nov; 65(21):1048-53. PubMed ID: 3431031
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Angiotensin-converting enzyme inhibition in type I diabetic nephropathy.
    Lewis EJ
    Contrib Nephrol; 1996; 118():206-13. PubMed ID: 8744059
    [No Abstract]   [Full Text] [Related]  

  • 59. A controlled clinical trial of angiotensin-converting enzyme inhibition in type I diabetic nephropathy: study design and patient characteristics. The Collaborative Study Group.
    Bain R; Rohde R; Hunsicker LG; McGill J; Kobrin S; Lewis EJ
    J Am Soc Nephrol; 1992 Oct; 3(4 Suppl):S97-103. PubMed ID: 1457767
    [TBL] [Abstract][Full Text] [Related]  

  • 60. [Nephropathy in non-insulin-dependent diabetics].
    Bouhanick B; Berrut G; Fabbri P; Fressinaud P; Marre M
    Presse Med; 1996 Sep; 25(27):1251-6. PubMed ID: 8949738
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.